Sugar-coated Bullets: Unveiling the Enigmatic Mystery 'sweet Arsenal' in Osteoarthritis

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Mar 18

PMID 38496870

Authors

Hong-Zhi Liu

Xin-Qiu Song

Hongmei Zhang

Affiliations

Soon will be listed here.

Abstract

Glycosylation is a crucial post-translational modification process where sugar molecules (glycans) are covalently linked to proteins, lipids, or other biomolecules. In this highly regulated and complex process, a series of enzymes are involved in adding, modifying, or removing sugar residues. This process plays a pivotal role in various biological functions, influencing the structure, stability, and functionality of the modified molecules. Glycosylation is essential in numerous biological processes, including cell adhesion, signal transduction, immune response, and biomolecular recognition. Dysregulation of glycosylation is associated with various diseases. Glycation, a post-translational modification characterized by the non-enzymatic attachment of sugar molecules to proteins, has also emerged as a crucial factor in various diseases. This review comprehensively explores the multifaceted role of glycation in disease pathogenesis, with a specific focus on its implications in osteoarthritis (OA). Glycosylation and glycation alterations wield a profound influence on OA pathogenesis, intertwining with disease onset and progression. Diverse studies underscore the multifaceted role of aberrant glycosylation in OA, particularly emphasizing its intricate relationship with joint tissue degradation and inflammatory cascades. Distinct glycosylation patterns, including N-glycans and O-glycans, showcase correlations with inflammatory cytokines, matrix metalloproteinases, and cellular senescence pathways, amplifying the degenerative processes within cartilage. Furthermore, the impact of advanced glycation end-products (AGEs) formation in OA pathophysiology unveils critical insights into glycosylation-driven chondrocyte behavior and extracellular matrix remodeling. These findings illuminate potential therapeutic targets and diagnostic markers, signaling a promising avenue for targeted interventions in OA management. In this comprehensive review, we aim to thoroughly examine the significant impact of glycosylation or AGEs in OA and explore its varied effects on other related conditions, such as liver-related diseases, immune system disorders, and cancers, among others. By emphasizing glycosylation's role beyond OA and its implications in other diseases, we uncover insights that extend beyond the immediate focus on OA, potentially revealing novel perspectives for diagnosing and treating OA.

References

Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T . Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med. 1988; 167(5):1731-6. PMC: 2188930. DOI: 10.1084/jem.167.5.1731. View

Joshi H, Hansen L, Narimatsu Y, Freeze H, Henrissat B, Bennett E . Glycosyltransferase genes that cause monogenic congenital disorders of glycosylation are distinct from glycosyltransferase genes associated with complex diseases. Glycobiology. 2018; 28(5):284-294. PMC: 6279177. DOI: 10.1093/glycob/cwy015. View

Luo Y, Wu Z, Chen S, Luo H, Mo X, Wang Y . Protein N-glycosylation aberrations and glycoproteomic network alterations in osteoarthritis and osteoarthritis with type 2 diabetes. Sci Rep. 2022; 12(1):6977. PMC: 9051103. DOI: 10.1038/s41598-022-10996-1. View

Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H . Osteoarthritis. Lancet. 2015; 386(9991):376-87. DOI: 10.1016/S0140-6736(14)60802-3. View

Croft D, Dall P, Davies D, Jackson D, McIntyre P, Kramer I . Complex CD44 splicing combinations in synovial fibroblasts from arthritic joints. Eur J Immunol. 1997; 27(7):1680-4. DOI: 10.1002/eji.1830270713. View

Gligorijevic N, Minic S, Krizakova M, Katrlik J, Nedic O . Structural changes of fibrinogen as a consequence of cirrhosis. Thromb Res. 2018; 166:43-49. DOI: 10.1016/j.thromres.2018.04.005. View

Ono M, Tsuda H, Kobayashi T, Takeshita F, Takahashi R, Tamura K . The expression and clinical significance of ribophorin II (RPN2) in human breast cancer. Pathol Int. 2015; 65(6):301-8. DOI: 10.1111/pin.12297. View

Li X, Jia F, Zhu Z, Huang L . Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes. Artif Cells Nanomed Biotechnol. 2019; 47(1):1256-1264. DOI: 10.1080/21691401.2019.1593996. View

Zoldos V, Novokmet M, Beceheli I, Lauc G . Genomics and epigenomics of the human glycome. Glycoconj J. 2012; 30(1):41-50. DOI: 10.1007/s10719-012-9397-y. View

10.

Langer B, Weisel J, Dinauer P, Nagaswami C, Bell W . Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem. 1988; 263(29):15056-63. View

11.

Huang S, Thomsson K, Jin C, Ryberg H, Das N, Struglics A . Truncated lubricin glycans in osteoarthritis stimulate the synoviocyte secretion of VEGFA, IL-8, and MIP-1: Interplay between -linked glycosylation and inflammatory cytokines. Front Mol Biosci. 2022; 9:942406. PMC: 9532613. DOI: 10.3389/fmolb.2022.942406. View

12.

Wu P, Hsieh Y, Lee K, Huang Y, Hou M, Lin H . Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients. PLoS One. 2021; 16(10):e0258589. PMC: 8516253. DOI: 10.1371/journal.pone.0258589. View

13.

Hsieh J, Longuet C, Maida A, Bahrami J, Xu E, Baker C . Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology. 2009; 137(3):997-1005, 1005.e1-4. DOI: 10.1053/j.gastro.2009.05.051. View

14.

Bond A, Cooke A, Hay F . Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Eur J Immunol. 1990; 20(10):2229-33. DOI: 10.1002/eji.1830201011. View

15.

Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P . EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006; 65(10):1312-24. PMC: 1798308. DOI: 10.1136/ard.2006.055269. View

16.

Kraus V, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M . Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage. 2011; 19(5):515-42. PMC: 3568396. DOI: 10.1016/j.joca.2010.08.019. View

17.

Wu J, Chen S, Liu H, Zhang Z, Ni Z, Chen J . Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation. J Exp Clin Cancer Res. 2018; 37(1):272. PMC: 6230241. DOI: 10.1186/s13046-018-0935-8. View

18.

Thompson S, Cantwell B, Matta K, Turner G . Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer. Cancer Lett. 1992; 65(2):115-21. DOI: 10.1016/0304-3835(92)90154-n. View

19.

Date K, Sakagami H, Yura K . Regulatory properties of vitronectin and its glycosylation in collagen fibril formation and collagen-degrading enzyme cathepsin K activity. Sci Rep. 2021; 11(1):12023. PMC: 8187593. DOI: 10.1038/s41598-021-91353-6. View

20.

Yu H, Takeuchi H . Protein O-glucosylation: another essential role of glucose in biology. Curr Opin Struct Biol. 2019; 56:64-71. DOI: 10.1016/j.sbi.2018.12.001. View